. | Dunne et al., 1999 (2) . | Ekbom et al., 2001 (3) . | Carr et al., 2006 (1)§ . | Current study . |
---|---|---|---|---|
Antihypertensive therapy strategy | Not specified | Preeclampsia diastolic BP >95 mmHg | Mean arterial BP ≥100 mmHg | BP >135/85 mmHg UAE ≥300 mg/24 h ACE inhibitor prepregnancy |
n | 21 | 11 | 43 | 7 |
Duration of diabetes (years) | 19.5 (12–30) | 16 (5) | 16.9 | 20 (5–32) |
A1C at inclusion (%) | 9.7 (6.7–16.7)‡ | 8.8 (1.3) | 8.1 | 6.6 (0.6) |
Antihypertensive therapy before pregnancy (n) | — | 6 (55%) | 18 (42%)* | 5 (71%) |
Patients on antihypertensive therapy during pregnancy (n) | — | — | 39 (90.7%) | 7 (100%) |
Systolic BP at inclusion (mmHg) | — | 129 (11) | 138 | 131 (19) |
Diastolic BP at inclusion (mmHg) | — | 77 (8) | 82 | 76 (9) |
UAE at inclusion (mg/24 h) | — | 1,120 (466–5,528) | 3,170 | 690 (450–3,290) |
Preeclampsia (n) | — | 7 (64%) | 15 (35%) | 3 (43%) |
Duration of pregnancy (days) | 243 (203–266) | — | 238 | 258 (220–260) |
Preterm delivery before 37 weeks (n) | 12 (57.2%) | 10 (91%) | 16 (38.1%)† | 5 (71%) |
Birth weight (g) | 2,429 (985–4,140) | 2,235 (1,038) | 2,200 | 2,730 (601) |
Small-for-gestational-age infants (<10th centile) | — | 5 (45%) | — | 2 (29%) |
Perinatal mortality (n) | 2 (10%) | 0 | 4 (9%) | 0 |
Major congenital malformations (n) | 1 (5%) | 1 (9%) | — | 0 |
. | Dunne et al., 1999 (2) . | Ekbom et al., 2001 (3) . | Carr et al., 2006 (1)§ . | Current study . |
---|---|---|---|---|
Antihypertensive therapy strategy | Not specified | Preeclampsia diastolic BP >95 mmHg | Mean arterial BP ≥100 mmHg | BP >135/85 mmHg UAE ≥300 mg/24 h ACE inhibitor prepregnancy |
n | 21 | 11 | 43 | 7 |
Duration of diabetes (years) | 19.5 (12–30) | 16 (5) | 16.9 | 20 (5–32) |
A1C at inclusion (%) | 9.7 (6.7–16.7)‡ | 8.8 (1.3) | 8.1 | 6.6 (0.6) |
Antihypertensive therapy before pregnancy (n) | — | 6 (55%) | 18 (42%)* | 5 (71%) |
Patients on antihypertensive therapy during pregnancy (n) | — | — | 39 (90.7%) | 7 (100%) |
Systolic BP at inclusion (mmHg) | — | 129 (11) | 138 | 131 (19) |
Diastolic BP at inclusion (mmHg) | — | 77 (8) | 82 | 76 (9) |
UAE at inclusion (mg/24 h) | — | 1,120 (466–5,528) | 3,170 | 690 (450–3,290) |
Preeclampsia (n) | — | 7 (64%) | 15 (35%) | 3 (43%) |
Duration of pregnancy (days) | 243 (203–266) | — | 238 | 258 (220–260) |
Preterm delivery before 37 weeks (n) | 12 (57.2%) | 10 (91%) | 16 (38.1%)† | 5 (71%) |
Birth weight (g) | 2,429 (985–4,140) | 2,235 (1,038) | 2,200 | 2,730 (601) |
Small-for-gestational-age infants (<10th centile) | — | 5 (45%) | — | 2 (29%) |
Perinatal mortality (n) | 2 (10%) | 0 | 4 (9%) | 0 |
Major congenital malformations (n) | 1 (5%) | 1 (9%) | — | 0 |
Data are means (SD), median (range), or n (%). A1C and birth weight in the current study are given as means (SD) to compare with previous results from our center (3). BP, blood pressure.
Patients using antihypertensive therapy at first visit.
Preterm delivery before 32 weeks.
Modified from Carr et al. (1) to constitute one group.
HbA1 or A1C (2).